# Crohn's Allogeneic Transplant Study

> **NCT01570348** · PHASE2 · TERMINATED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 2 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **PROCEDURE:** Allogeneic Bone Marrow Transplantation
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine Phosphate
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Mycophenolic Acid
- **OTHER:** Quality-of-Life Assessment
- **DRUG:** Tacrolimus
- **RADIATION:** Total-Body Irradiation

## Key facts

- **NCT ID:** NCT01570348
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07-17
- **Primary completion:** 2019-02-03
- **Final completion:** 2019-10-30
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Annual accrual goal not met
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01570348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01570348, "Crohn's Allogeneic Transplant Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01570348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*